Home > Financial Ratios > LYKA LABS

LYKA LABS
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.261.421.800.982.27

What is the latest Fixed Capital/Sales ratio of LYKA LABS ?

The latest Fixed Capital/Sales ratio of LYKA LABS is 1.26 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20251.26
Mar20241.42
Mar20231.80
Mar20220.98
Mar20212.27

How is Fixed Capital/Sales of LYKA LABS Trending?

Years Fixed Capital/Sales % Change
Mar2025 1.26
-11.27
Mar2024 1.42
-21.11
Mar2023 1.8
83.67
Mar2022 0.98
-56.83
Mar2021 2.27 -

Other Financial Ratios of LYKA LABS


Compare Fixed Capital/Sales ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹202.3 Cr -7.7% -19.9% -43.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,999.0 Cr 3.6% 7% 15.3% Stock Analytics
DIVIS LABORATORIES ₹169,139.0 Cr 1.1% 5.8% 14.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,791.0 Cr 1.9% 12.3% 49.2% Stock Analytics
DR REDDYS LABORATORIES ₹109,664.0 Cr 1.8% 5.9% 14.8% Stock Analytics
CIPLA ₹107,685.0 Cr 1.6% 0.2% -5.4% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-7.7%

-19.9%

-43.8%

SENSEX

-2.5%

-6.1%

7%


You may also like the below Video Courses